Topical antibacterial therapy for mycobacterial keratitis: Potential for surgical prophylaxis and treatment

Clinical Therapeutics

Volumn 26, Issue 2, 2004, Pages 191-196

  Abshire, Robert ^a   Cockrum, Paul ^a   Crider, Julie ^a   Schlech, Barry ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

Atypical mycobacterial keratitis; Ciprofloxacin; Fluoroquinolone; Gatifloxacin; Levofloxacin; Moxifloxacin; Ofloxacin

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; BIOMEDICINE; BIOSIS; DATA BASE; DRUG POTENCY; EMBASE; EYE SURGERY; IN VITRO STUDY; KERATITIS; KERATOMILEUSIS; MEDLINE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; NONHUMAN; PROPHYLAXIS; REVIEW; SURGICAL INFECTION; TOPICAL TREATMENT;

EID: 1542511330     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(04)90018-5     Document Type: Article

References (32)

1. Huang SC, Soong HK, Chang JS, Liang YS. Nontuberculous mycobacterial keratitis: A study of 22 cases. Br J Ophthalmol. 1996;80:962-968.
2. Ford JG, Huang AJ, Pflugfelder SC, et al. Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology. 1998;105:1652-1658.
3. Turner L, Stinson I. Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol. 1965;60:329-331.
4. Gangadharam PR, Lanier JD, Jones DE. Keratitis due to Mycobacterium chelonei. Tubercle. 1978;59:55-60.
5. Margo CE, Pavan PR. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol. 2000;118:1125-1128.
6. Garg P, Bansal AK, Sharma S, Vemuganti GK. Bilateral infectious keratitis after laser in situ keratomileusis: A case report and review of the literature. Ophthalmology. 2001;108:121-125.
7. Pushker N, Dada T, Sony P, et al. Microbial keratitis after laser in situ keratomileusis. J Refract Surg. 2002;18:280-286.
8. Dugel PU, Holland GN, Brown HH, et al. Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1988;105:661-669.
9. Newman PE, Goodman RA, Waring GO III, et al. A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol. 1984;97:344-348.
10. Robin JB, Beatty RF, Dunn S, et al. Mycobacterium chelonei keratitis after radial keratotomy. Am J Ophthalmol. 1986;102:72-79.
11. Hsiao CH, Chen JJ, Huang SC, et al. Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol. 1998;82:29-34.
12. Roussel TJ, Stern WH, Goodman DF, Whitcher JP. Postoperative mycobacterial endophthalmitis. Am J Ophthalmol. 1989;107:403-406.
13. Khooshabeh R, Grange JM, Yates MD, et al. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis. 1994;75:377-382.
14. Reviglio V, Rodriguez ML, Picotti GS, et al. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg. 1998;14:357-360.
15. Gelender H, Carter HL, Bowman B, et al. Mycobacterium keratitis after laser in situ keratomileusis. J Refract Surg. 2000;16:191-195.
16. Wallace RJ Jr, Dalovisio JR, Pankey GA. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antimicrobial agents. Antimicrob Agents Chemother. 1979;16:611-614.
17. Machat J. LASIK complications and their management. In: Machat J, ed. Eximer Laser Refractive Surgery: Practice and Principles. Thorofare, NJ: Slack, Inc; 1996: 359-400.
18. Biswell R. Cornea. In: Vaughan D, Asbury T, Riordan-Eva P, eds. General Ophthalmology. 15th ed. Stamford, Conn: Appleton & Lange; 1999:119-141.
19. Helm CJ, Holland GN, Lin R, et al. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. Am J Ophthalmol. 1993;116:700-707.
20. Dalovisio JR, Pankey GA. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis. 1978;137:318-321.
21. Hu FR, Luh KT. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Ophthalmology. 1998;105:269-272.
22. Gomez-Rodriguez AJ, Ruiz-Serrano MJ, Cuevas O, et al. Comparative in vitro activities of moxifloxacin and linezolid with other agents against rapidly growing mycobacteria. 42nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30, 2002; San Diego, Calif. Abstract E-40.
23. Yew WW, Piddock LJ, Li MS, et al. In vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother. 1994;34:343-351.
24. Wallace RJ Jr, Bedsole G, Sumter G, et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother. 1990;34:65-70.
25. Tomioka H, Saito H, Sato K. Comparative antimycobacterial activity of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin. Antimicrob Agents Chemother. 1993;37:1259-1263.
26. Rastogi N, Goh KS, Bryskier A, Devallois A. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine. Antimicrob Agents Chemother. 1996;40:2483-2487.
27. Saito H. Comparative antimycobacterial activity of BAY 12-8039 and gatifloxacin. Drugs. 1999;58(Suppl 2): 400-401.
28. Meisler DM, Friedlaender MH, Okumoto M. Mycobacterium chelonei keratitis. Am J Ophthalrnol. 1982;94:398-401.
29. Matoba A. Mycobacterium chelonae keratitis. Am J Ophthalmol. 1987;103:595-596.
30. Lois N, Perez del Molino ML. Mycobacterium chelonae keratitis: Resolution after debridement and presoaked collagen shields. Cornea. 1995;14:536-539.
31. Gillespie SH, Billington O. Activity of moxifloxacin against mycobacteria. J Antimicrob Chemother. 1999;44:393-395.
32. Gillespie SH, Morrissey I, Everett D. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. J Med Microbiol. 2001;50:565-570.